trending Market Intelligence /marketintelligence/en/news-insights/trending/ACHuwL_HsK7iZKMnmfhONQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Moody's affirms ratings on AmerisourceBergen

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Moody's affirms ratings on AmerisourceBergen

Moody's affirmed AmerisourceBergen Corp.'s Baa2 senior unsecured rating and said the outlook on the rating was stable.

The rating agency said the affirmation is based on the expectation that the drug distributor will have $1.5 billion of free cash flow after paying annual dividends over the next three years.

According to Moody's, AmerisourceBergen will sustain moderate leverage and a significant operating scale over the next 12 to 18 months.

Additionally, the rating agency expects the company to have a practical approach toward acquisitions and share repurchases, as long as risks related to opioid litigation-related liabilities are clarified.

Under a proposed settlement in that litigation, AmerisourceBergen will pay $5.58 billion in cash over 18 years to resolve outstanding legal matters with cities, counties and states throughout the U.S.

Moreover, the company will provide product distribution and monitoring services over a 10-year period amounting to another $930 million, according to the office of North Carolina's attorney general.